Main Menu
Menu

Blog

Publish Date
BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

Blog
C4IP Coalition Updates: November 2025

November Highlights: The Upcoming Review of the USMCA This fall marked the beginning of the first scheduled Joint Review process for the...

Blog
This Month in IP: November 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From gardening...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

Blog
Inventor Spotlight: Ronald Rivest, Adi Shamir, and Leonard Adleman

C4IP is honoring Ronald Rivest (born 1947), Adi Shamir (b. 1952), and Leonard Adleman (b. 1945), whose invention of RSA cryptography forms...

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

Blog
‘Tis the Season — of Counterfeits?

Counterfeiting is a multi-billion-dollar enterprise that puts consumers at serious risk. Poorly-made laptop batteries can overheat. Knock-off cosmetics may contain toxic chemicals....

Blog
This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

Blog
C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Blog
Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Blog:

Blog, Fact Checks:

The SHOP SAFE Act Would Benefit Consumers and Small Businesses,

11/27/2023
Blog:

Blog:

Celebrating American Innovation: Edwin Armstrong,

11/20/2023
Op-Eds:

Blog, Op-Eds:

The US patent system is weakened. New Congressional legislation could fix it,

11/11/2023
Op-Eds:

Blog, Op-Eds:

Biden must decide whether patent-infringing Apple watches can be imported into the U.S. from China by Christmas–but Congress could neuter America’s ability to protect its IP altogether,

11/10/2023
Op-Eds:

Blog, Op-Eds:

Congress’ latest patent legislation a big win for entrepreneurs, small businesses,

11/04/2023
Op-Eds:

Blog, Op-Eds:

Help American inventors bolster national security,

11/02/2023
Blog:

Blog:

C4IP Coalition Updates: October 2023,

11/01/2023
Blog:

Blog:

This Month in IP: October 2023,

11/01/2023
Blog:

Blog:

Patents, Pumpkins, and Pageantry: The IP Behind Halloween,

10/27/2023
Blog:

Blog, Fact Checks:

Fact Check: PTAB Reform Would Benefit, Not Harm, Small Inventors,

10/20/2023
Blog:

Blog:

Celebrating American Innovation: Bill Bowerman,

10/12/2023
Op-Eds:

Blog, Op-Eds:

Democrats, Republicans must come together again to protect our culture of innovation,

10/06/2023
Scroll to Top